Quantitative Assessment of CYP2C9 Genetic Polymorphisms Effect on the Oral Clearance of S-Warfarin in Healthy Subjects

被引：0
作者：
Chanan Shaul
Simcha Blotnick
Mordechai Muszkat
Meir Bialer
Yoseph Caraco
机构：
[1] Hadassah-Hebrew University Medical Center,Clinical Pharmacology Unit, Division of Medicine
[2] Hebrew University,Institute of Drug Research, School of Pharmacy, Faculty of Medicine
来源：
Molecular Diagnosis & Therapy | 2017年 / 21卷
关键词：
Warfarin; Variant Allele; Warfarin Dose; Oral Clearance; CYP2C9 Genotype;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：75 / 83
页数：8
相关论文
共 50 条
[21]   Clinical relevance of genetic polymorphisms in the human CYP2C9 gene [J].
Schwarz, UI .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2003, 33 :23-30
[22]   Upstream and coding region CYP2C9 polymorphisms: correlation with warfarin dose and metabolism [J].
King, BP ;
Khan, TI ;
Aithal, GP ;
Kamali, F ;
Daly, AK .
PHARMACOGENETICS, 2004, 14 (12) :813-822
[23]   Genetic Polymorphism of the CYP2C9 Subfamily of 3 Different Races in Warfarin Maintenance Dose [J].
Gin Gin Gan ;
Alan Teh ;
Vijaya Sangkar ;
Maude Elvira Phipps ;
Chee Seng Ku .
International Journal of Hematology, 2004, 80 :295-296
[24]   Interethnic and Intraethnic Variability of CYP2C8 and CYP2C9 Polymorphisms in Healthy Individuals [J].
Elena García-Martín ;
Carmen Martínez ;
José M. Ladero ;
José A. G. Agúndez .
Molecular Diagnosis & Therapy, 2006, 10 :29-40
[25]   CYP2C9 polymorphism affects warfarin complications [J].
Reactions Weekly, 1999, 741 (1) :4-4
[26]   Warfarin analog inhibition of human CYP2C9-catalyzed S-warfarin 7-hydroxylation [J].
Zhang, ZY ;
Kerr, J ;
Wexler, RS ;
Li, HY ;
Robinson, AJ ;
Harlow, PP ;
Kaminsky, LS .
THROMBOSIS RESEARCH, 1997, 88 (04) :389-398
[27]   Association between CYP2C9 and VKORC1 genetic polymorphisms and efficacy and safety of warfarin in Chinese patients [J].
Zhang, Suli ;
Zhao, Mingzhe ;
Zhong, Shilong ;
Niu, Jiamin ;
Zhou, Lijuan ;
Zhu, Bin ;
Su, Haili ;
Cao, Wei ;
Xing, Qinghe ;
Yan, Hongli ;
Han, Xia ;
Fu, Qihua ;
Li, Qiang ;
Chen, Luan ;
Yang, Fan ;
Zhang, Na ;
Wu, Hao ;
He, Lin ;
Qin, Shengying .
PHARMACOGENETICS AND GENOMICS, 2024, 34 (04) :105-116
[28]   Effect of CYP2C9*2 and VKORC-1639G/A Polymorphisms on Warfarin Doses Requirements in Sudanese Patients [J].
Elsadig, Ahmed Elhadi ;
Muddath, Abdel Rahim M. ;
Elamin, Elwaleed M. ;
Shrif, Nasr Eldin Ma ;
Waggiallah, Hisham Ali .
INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2022, 18 (07) :1366-1373
[29]   Frequency of Common CYP2C9 Polymorphisms and Their Impact on Warfarin Dose Requirement in Pakistani Population [J].
Qayyum, Aisha ;
Najmi, Muzammil Hasan ;
Mansoor, Qaisar ;
Farooqi, Zia-ur-Rehman ;
Naveed, Abdul Khaliq ;
Hanif, Andleeb ;
Kazmi, Syed Ali Raza ;
Ismail, Muhammad .
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2017, 23 (07) :800-806
[30]   Polymorphisms of VKORC1 and CYP2C9 are associated with warfarin sensitivity in Chinese population [J].
Jia, LiQun ;
Wang, Zanxin ;
Men, Jianlong ;
Cai, Heng ;
Wei, Minxin .
THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2017, 13 :421-425
12345